Pilot Pharmacokinetic Study of Investigational Sublingual Nicotine Tablet Versus COMMIT Nicotine Lozenge

计划入组 6 人 · 首次发布于 2013 年 6 月 27 日

Maximum Treatment Interval With Aflibercept T&E

计划入组 100 人 · 首次发布于 2022 年 4 月 25 日

To Demonstrate the Relative Bioequivalency Comparing Geneva's 10 mg Glipizide Tablets To Roerig's 10 mg Glucotrol Tablets

计划入组 28 人 · 首次发布于 2009 年 7 月 27 日

CLDN18.2 UCAR-T(Suzhou Maximum Bio-tech)

MT-026

CD19 UCAR-T

Affini-T Therapeutics, Inc.

United States

RUSS T. SHIMIZU, M.D., INC.

United States

T & C Flynn's Pharmacy Inc

United States

T-MAXIMUM's Universal CAR-T MT027 to Debut Brain Metastasis Data at WCLC 2026 as Intracranial Tumors Emerge as Solid Tumor CAR-T's Second Battlefield

T-MAXIMUM's Allogeneic CAR-T Therapy MT027 Receives FDA Clearance for Phase II Glioblastoma Trial

Ultragenyx's GTX-102 Shows Promise in Angelman Syndrome Phase 1/2 Trial